Article R5121-61 of the French Public Health Code
The Director General of the Agence nationale de sécurité du médicament et des produits de santé will arrange for the Agency’s inspectors to take samples of proprietary medicinal products to ensure that they comply with the declared formulation. The samples taken are placed in bags bearing a label specifying the name and batch number of the medicinal product, the date of sampling, the reason for sampling and the name of…